ClearPoint Neuro
CLPT14.5803.11% ( +0.440 )
ClearPoint Neuro (CLPT)
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasi...
- Open
- 14.260
- High
- 14.680
- Low
- 14.040
- Prev. Close
- 14.140
- Volume
- 438.83K
- Turnover
- 6.36M
- Avg Price
- 14.484
- Bid/Ask Ratio
- --
- Amplitude
- 4.53%
- 52wk High
- 30.100
- Volume Ratio
- 0.83
- Turnover Ratio
- 1.67%
ClearPoint Neuro Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$28.3394.33%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 2 days ago, 08:23 AM
Community Financial System posts Q2 2026 net income $61.3M; diluted EPS $1.16, revenues $223.2M
- Market Beat · Jul 27 at 06:41 AM
ClearPoint Neuro (CLPT) Projected to Announce Quarterly Earnings on Monday
- PUBT · Jul 21 at 03:05 PM
ClearPoint Neuro schedules Q2 2026 earnings release and conference call
- PharmaTimes · Jul 16 at 07:37 AM
EpilepsyGTx and ClearPoint Neuro join forces on targeted therapy
- PUBT · Jul 1 at 05:43 PM
ClearPoint Neuro CEO Joseph Burnett disposes of 20,000 common shares for $387,600
- PUBT · Jun 22 at 03:05 PM
ClearPoint Neuro CEO Joseph Burnett disposes of common shares worth $1.1 million
